Showing results (3091-3100 of 10,589) with videos related to
Sort By:
Pageof 1,059
Thrombosis Research|October 20, 2022
Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosisMichael Etscheid, Kay-Martin Hanschmann, Per Morten Sandset, et al.Thrombosis Research|October 20, 2022
Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanismsLennart Beckmann, Jonathan Mäder, Minna Voigtlaender, et al.Thrombosis Research|October 22, 2022
Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER)Nicolas Wenger, Tim Sebastian, Jürg H Beer, et al.Thrombosis Research|August 15, 1986
Interaction of platelets and purified collagens in a laminar flow modelT J Parsons, D L Haycraft, J C Hoak, et al.Thrombosis Research|September 15, 1986
Studies on liposome-encapsulated heparinT D Kim, M Sakon, T Kawasaki, et al.Thrombosis Research|September 15, 1986
Heparin fractions with high and low affinities to antithrombin III are cleared at different ratesC Caranobe, M Petitou, D Dupouy, et al.Thrombosis Research|October 20, 2022
Tissue factor in COVID-19-associated coagulopathySaravanan Subramaniam, Hema Kothari, Markus BosmannThrombosis Research|June 1, 1987
Monitoring of heparin therapy: should heparin assays also reflect the patient's antithrombin concentration?H A Holm, U Abildgaard, M L Larsen, et al.Thrombosis Research|June 1, 1987
Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragmentE Persson, J Nordenström, L Hagenfeldt, et al.Thrombosis Research|August 1, 1987
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolamC P Cox, K L WoodPageof 1,059